BMC Clinical Pharmacology

Table 10 Determination of MIC and MLC for Meropenem

From: Comparative in vitrostudy of the antimicrobial activities of different commercial antibiotic products for intravenous administration

Strain	MIC (μg/ml)			MLC (μg/ml)
	Std	M1	M2	Std	M1	M2
Ps. aeruginosa 151	3.9	3.9	3.9	7.8	7.8	7.8
Ps. aeruginosa 157	15.6	15.6	15.6	31.3	31.3	31.3
Ps. aeruginosa ATCC 25619	31.3	31.3	31.3	62.5	62.5	62.5
Ps. aeruginosa 74	31.3	31.3	31.3	62.5	62.5	62.5
Ps. aeruginosa 142	15.6	15.6	15.6	31.3	31.3	31.3
A. baumanii 59	62.5	62.5	62.5	125	125	125
A. baumanii 147	15.6	15.6	15.6	31.3	31.3	31.3
A. baumanii 173	0.98	0.98	0.98	1.95	1.95	1.95
A. baumanii 189	15.6	15.6	15.6	31.3	31.3	31.3
E. coli 39	3.91	3.91	3.91	7.8	7.8	7.8
E. coli 50	62.5	62.5	62.5	125	125	125
E. coli 69	31.3	31.3	31.3	125	125	125
E. coli ATCC 13706	≥ 500	≥ 500	≥ 500	≥ 500	≥ 500	≥ 500
S. faecalis	≥ 500	≥ 500	≥ 500	≥ 500	≥ 500	≥ 500
S. faecalis ATCC 29212	31.3	31.3	31.3	62.5	62.5	62.5
S. faecalis ATCC 319623	31.3	31.3	31.3	62.5	62.5	62.5
E. gallinarum	15.6	15.6	15.6	31.3	31.3	31.3
K. pneumoniae 1	62.5	62.5	62.5	125	125	125
K. pneumoniae 43	250	250	250	≥ 500	≥ 500	≥ 500
K. pneumoniae 63	31.3	31.3	31.3	125	125	125
K. pneumoniae 65	15.6	15.6	15.6	31.3	31.3	31.3
K. pneumoniae 207	3.9	3.9	3.9	7.8	7.8	7.8
K. pneumoniae ATCC10031	125	125	125	250	250	250

Back to article page